Within the IDHwt GBM subgroup (n = 22), MGMT-methylated tumors (n = 7) had a mean time to second recurrence of 11.1 months (95% CI: 4.4–17.6), median 8.4 months [IQR: 4.8–17.3]. The gene discussed is MGMT; the disease is glioblastoma.